Genetic determinants of acute renal damage risk and prognosis: A systematic review;Determinantes genéticos del riesgo y pronóstico del daño renal agudo: Una revisión sistemática

Medicina Intensiva

Volumn 36, Issue 9, 2012, Pages 626-633

  Cardinal Fernandez P ^a,b   Ferruelo, A ^a,b   Martin Pellicer A ^a,b   Nin, N ^a,b   Esteban, A ^a,b   Lorente, J A ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Genetic predisposition; Polymorphism; Susceptibility; Susceptibility to acute renal damage

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; APOLIPOPROTEIN E; CATECHOL METHYLTRANSFERASE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 10; INTERLEUKIN 6; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANGIOTENSIN 1 RECEPTOR GENE; APOLIPOPROTEIN E GENE; ARTICLE; CATECHOL METHYLTRANSFERASE GENE; CONTROLLED STUDY; DIPEPTIDYL CARBOXYPEPTIDASE GENE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; ERYTHROPOIETIN GENE; FNMT GENE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA GENE; INFLAMMATION; INTERLEUKIN 10 GENE; INTERLEUKIN 6 GENE; KIDNEY TRANSPLANTATION; LIPID METABOLISM; MAJOR CLINICAL STUDY; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE GENE; OXIDATIVE STRESS; PROGNOSIS; RECEPTOR GENE; REGULATORY MECHANISM; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SYSTEMATIC REVIEW; TUMOR NECROSIS FACTOR ALPHA GENE;

ACUTE KIDNEY INJURY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS;

EID: 84870237359     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2012.02.002     Document Type: Article

References (35)

1. Nin N., Lombardi R., Frutos-Vivar F., Esteban A., Lorente J.A., Ferguson N.D., et al. Early and small changes in serum creatinine concentrations are associated with mortality in mechanically ventilated patients. Shock 2010, 34:109-116.
2. Hou S.H., Bushinsky D.A., Wish J.B., Cohen J.J., Harrington J.T. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983, 74:243-248.
3. Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002, 39:930-936.
4. Herrera-Gutierrez M.E., Seller-Perez G., Maynar-Moliner J. Epidemiology of acute kidney failure in Spanish ICU. Multicenter prospective study FRAMI. Med Intensiva 2006, 30:260-267.
5. Guttmacher A.E., Collins F.S. Genomic medicine--a primer. N Engl J Med 2002, 347:1512-1520.
6. Attia J., Ioannidis J.P., Thakkinstian A., McEvoy M., Scott R.J., Minelli C., et al. How to use an article about genetic association: A: Background concepts. JAMA 2009, 301:74-81.
7. Raggio V., Roche L. Perfil genómico de riesgo en la práctica clínica. Rev Med Urug 2009, 25:45-58.
8. Sirgo G., Rello J., Bodi M., Díaz E., Pérez-Vela J.L., Hernández G., et al. Polimorfismo genético en el paciente crítico (I). Aspectos generales, inflamación y sepsis. Med Intensiva 2003, 27:24-31.
9. Sirgo G., Rello J., Bodí M., Díaz E., Pérez-Vela J.L., Hernández G., et al. Polimorfismo genético en el paciente crítico. Parte II: aplicaciones especiales de los polimorfismos genéticos. Farmacogenética y terapia génica. Med Intensiva 2003, 27:181-187.
10. Cardinal-Fernandez P., Nin N., Lorente J.A. Acute lung injury and acute respiratory distress syndrome: a genomic perspective. Med Intensiva 2011, 35:361-372.
11. Du Cheyron D., Fradin S., Ramakers M., Terzi N., Guillotin D., Bouchet B., et al. Angiotensin converting enzyme insertion/deletion genetic polymorphism: its impact on renal function in critically ill patients. Crit Care Med 2008, 36:3178-3183.
12. Pedroso J.A., Paskulin D., Dias F.S., De França E., Alho C.S. Temporal trends in acute renal dysfunction among critically ill patients according to I/D and -262A>T ACE polymorphisms. J Bras Nefrol 2010, 32:182-194.
13. Jaber B.L., Rao M., Guo D., Balakrishnan V.S., Perianayagam M.C., Freeman R.B., et al. Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 2004, 25:212-219.
14. Perianayagam M.C., Liangos O., Kolyada A.Y., Wald R., MacKinnon R.W., Li L., et al. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007, 18:255-263.
15. Kolyada A.Y., Tighiouart H., Perianayagam M.C., Liangos O., Madias N.E., Jaber B.L. A genetic variant of hypoxia-inducible factor-1alpha is associated with adverse outcomes in acute kidney injury. Kidney Int 2009, 75:1322-1329.
16. Alam A., O'Connor D.T., Perianayagam M.C., Kolyada A.Y., Chen Y., Rao F., et al. Phenylethanolamine N-methyltransferase gene polymorphisms and adverse outcomes in acute kidney injury. Nephron Clin Pract 2010, 114:c253-c259.
17. Popov A.F., Schulz E.G., Schmitto J.D., Coskun K.O., Tzvetkov M.V., Kazmaier S., et al. Relation between renal dysfunction requiring renal replacement therapy and promoter polymorphism of the erythropoietin gene in cardiac surgery. Artif Organs 2010, 34:961-968.
18. Popov A.F., Hinz J., Schulz E.G., Schmitto J.D., Wiese C.H., Quintel M., et al. The eNOS 786C/T polymorphism in cardiac surgical patients with cardiopulmonary bypass is associated with renal dysfunction. Eur J Cardiothorac Surg 2009, 36:651-656.
19. MacKensen G.B., Swaminathan M., Ti L.K., Grocott H.P., Phillips-Bute B.G., Mathew J.P., et al. Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG. Ann Thorac Surg 2004, 78:520-526.
20. Haase-Fielitz A., Haase M., Bellomo R., Lambert G., Matalanis G., Story D., et al. Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol 2009, 20:1393-1403.
21. Isbir S.C., Tekeli A., Ergen A., Yilmaz H., Ak K., Civelek A., et al. Genetic polymorphisms contribute to acute kidney injury after coronary artery bypass grafting. Heart Surg Forum 2007, 10:E439-E444.
22. Stafford-Smith M., Podgoreanu M., Swaminathan M., Phillips-Bute B., Mathew J.P., Hauser, et al. Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis 2005, 45:519-530.
23. Licker M., Cartier V., Robert J., Diaper J., Villiger Y., Tschopp J.M., et al. Risk factors of acute kidney injury according to RIFLE criteria after lung cancer surgery. Ann Thorac Surg 2011, 91:844-850.
24. Torras J., Cruzado J.M., Herrero-Fresneda I., Grinyo J.M. Gene therapy for acute renal failure. Contrib Nephrol 2008, 159:96-108.
25. Chien C.T., Chang T.C., Tsai C.Y., Shyue S.K., Lai M.K. Adenovirus-mediated bcl-2 gene transfer inhibits renal ischemia/reperfusion induced tubular oxidative stress and apoptosis. Am J Transplant 2005, 5:1194-1203.
26. Weinshilboum R.M., Raymond F.A. Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. Am J Hum Genet 1977, 29:125-135.
27. Inoue N., Kawashima S., Kanazawa K., Yamada S., Akita H., Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998, 97:135-137.
28. Guzik T.J., West N.E., Black E., McDonald D., Ratnatunga C., Pillai R., et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000, 102:1744-1747.
29. Wyche K.E., Wang S.S., Griendling K.K., Dikalov S.I., Austin H., Rao S., et al. C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 2004, 43:1246-1251.
30. Semenza G.L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000, 88:1474-1480.
31. Roukos D.H. Networks medicine: from reductionism to evidence of complex dynamic biomolecular interactions. Pharmacogenomics 2011, 12:695-698.
32. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 2009, 106:9362-9367.
33. Alberts B. Model organisms and human health. Science 2010, 330:1724.
34. Blaxter M. Genetics. Revealing the dark matter of the genome. Science 2010, 330:1758-1759.
35. Kelly T.K., De Carvalho D.D., Jones P.A. Epigenetic modifications as therapeutic targets. Nat Biotechnol 2010, 28:1069-1078.